241 related articles for article (PubMed ID: 22403683)
1. Evidence for the contribution of the hemozoin synthesis pathway of the murine Plasmodium yoelii to the resistance to artemisinin-related drugs.
Witkowski B; Lelièvre J; Nicolau-Travers ML; Iriart X; Njomnang Soh P; Bousejra-Elgarah F; Meunier B; Berry A; Benoit-Vical F
PLoS One; 2012; 7(3):e32620. PubMed ID: 22403683
[TBL] [Abstract][Full Text] [Related]
2. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
[TBL] [Abstract][Full Text] [Related]
3. Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite.
Pandey AV; Tekwani BL; Singh RL; Chauhan VS
J Biol Chem; 1999 Jul; 274(27):19383-8. PubMed ID: 10383451
[TBL] [Abstract][Full Text] [Related]
4. A Variant PfCRT Isoform Can Contribute to
Dhingra SK; Redhi D; Combrinck JM; Yeo T; Okombo J; Henrich PP; Cowell AN; Gupta P; Stegman ML; Hoke JM; Cooper RA; Winzeler E; Mok S; Egan TJ; Fidock DA
mBio; 2017 May; 8(3):. PubMed ID: 28487425
[TBL] [Abstract][Full Text] [Related]
5. Correlation between Plasmodium yoelii nigeriensis susceptibility to artemisinin and alkylation of heme by the drug.
Robert A; Claparols C; Witkowski B; Benoit-Vical F
Antimicrob Agents Chemother; 2013 Aug; 57(8):3998-4000. PubMed ID: 23752508
[TBL] [Abstract][Full Text] [Related]
6. Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials.
Aratikatla EK; Kalamuddin M; Rana KC; Datta G; Asad M; Sundararaman S; Malhotra P; Mohmmed A; Bhattacharya AK
Eur J Med Chem; 2021 Aug; 220():113454. PubMed ID: 33901900
[TBL] [Abstract][Full Text] [Related]
7. Cellular mechanisms of action and resistance of Plasmodium falciparum to artemisinin.
Phompradit P; Chaijaroenkul W; Na-Bangchang K
Parasitol Res; 2017 Dec; 116(12):3331-3339. PubMed ID: 29127525
[TBL] [Abstract][Full Text] [Related]
8. A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
Bosson-Vanga H; Primas N; Franetich JF; Lavazec C; Gomez L; Ashraf K; Tefit M; Soulard V; Dereuddre-Bosquet N; Le Grand R; Donnette M; Mustière R; Amanzougaghene N; Tajeri S; Suzanne P; Malzert-Fréon A; Rault S; Vanelle P; Hutter S; Cohen A; Snounou G; Roques P; Azas N; Lagardère P; Lisowski V; Masurier N; Nguyen M; Paloque L; Benoit-Vical F; Verhaeghe P; Mazier D
Microbiol Spectr; 2021 Oct; 9(2):e0027421. PubMed ID: 34724729
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of artemisinin resistance in the rodent malaria pathogen Plasmodium yoelii.
Walker DJ; Pitsch JL; Peng MM; Robinson BL; Peters W; Bhisutthibhan J; Meshnick SR
Antimicrob Agents Chemother; 2000 Feb; 44(2):344-7. PubMed ID: 10639360
[TBL] [Abstract][Full Text] [Related]
10. Ketoconazole, a cytochrome P(450) inhibitor can potentiate the antimalarial action of α/β arteether against MDR Plasmodium yoelii nigeriensis.
Tripathi R; Rizvi A; Pandey SK; Dwivedi H; Saxena JK
Acta Trop; 2013 May; 126(2):150-5. PubMed ID: 23391499
[TBL] [Abstract][Full Text] [Related]
11. Cloning, expression and functional characterization of heme detoxification protein (HDP) from the rodent malaria parasite Plasmodium vinckei.
Soni A; Goyal M; Prakash K; Bhardwaj J; Siddiqui AJ; Puri SK
Gene; 2015 Jul; 566(1):109-19. PubMed ID: 25891072
[TBL] [Abstract][Full Text] [Related]
12. No evidence of amplified Plasmodium falciparum plasmepsin II gene copy number in an area with artemisinin-resistant malaria along the China-Myanmar border.
Huang F; Shrestha B; Liu H; Tang LH; Zhou SS; Zhou XN; Takala-Harrison S; Ringwald P; Nyunt MM; Plowe CV
Malar J; 2020 Sep; 19(1):334. PubMed ID: 32928233
[TBL] [Abstract][Full Text] [Related]
13. In vitro selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemisinin.
Njokah MJ; Kang'ethe JN; Kinyua J; Kariuki D; Kimani FT
Malar J; 2016 Jul; 15(1):381. PubMed ID: 27449110
[TBL] [Abstract][Full Text] [Related]
14. Geographic expansion of artemisinin resistance.
Müller O; Lu GY; von Seidlein L
J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30995310
[TBL] [Abstract][Full Text] [Related]
15. Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance.
Krishna S; Woodrow CJ; Staines HM; Haynes RK; Mercereau-Puijalon O
Trends Mol Med; 2006 May; 12(5):200-5. PubMed ID: 16616639
[TBL] [Abstract][Full Text] [Related]
16. A crucial piece in the puzzle of the artemisinin resistance mechanism in Plasmodium falciparum.
Bozdech Z; Ferreira PE; Mok S
Trends Parasitol; 2015 Aug; 31(8):345-6. PubMed ID: 26169358
[TBL] [Abstract][Full Text] [Related]
17. Plasmodium yoelii: identification and partial characterization of an MDR1 gene in an artemisinin-resistant line.
Ferrer-Rodríguez I; Pérez-Rosado J; Gervais GW; Peters W; Robinson BL; Serrano AE
J Parasitol; 2004 Feb; 90(1):152-60. PubMed ID: 15040683
[TBL] [Abstract][Full Text] [Related]
18. Dihydroartemisinin-Ferriprotoporphyrin IX Adduct Abundance in Plasmodium falciparum Malarial Parasites and the Relationship to Emerging Artemisinin Resistance.
Heller LE; Goggins E; Roepe PD
Biochemistry; 2018 Dec; 57(51):6935-6945. PubMed ID: 30512926
[TBL] [Abstract][Full Text] [Related]
19. Triple Artemisinin-Based Combination Therapies for Malaria - A New Paradigm?
van der Pluijm RW; Amaratunga C; Dhorda M; Dondorp AM
Trends Parasitol; 2021 Jan; 37(1):15-24. PubMed ID: 33060063
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and genotypic characterization of Thai isolates of Plasmodium falciparum after an artemisinin resistance containment project.
Thita T; Jadsri P; Thamkhantho J; Ruang-Areerate T; Suwandittakul N; Sitthichot N; Mahotorn K; Tan-Ariya P; Mungthin M
Malar J; 2018 May; 17(1):197. PubMed ID: 29764451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
